US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Virtus LifeSci Biotech Products ETF

102.50

-0.7073-0.69%

Post-market: 102.36-0.1428-0.14%19:30 EDT

Volume:18.72K

Turnover:1.92M

Market Cap:128.12M

PE:- -

High:103.87

Open:103.87

Low:102.00

Close:103.21

52wk High:110.05

52wk Low:70.27

Shares:1.25M

Float Shares:1.25M

Volume Ratio:1.09

T/O Rate:1.50%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Bank of England’s Ramsden says interest rates will need to rise if pressures persist

Zymeworks sees FY26 revenue $278M-$292M, consensus $304.04M

Ichigo Office REIT Locks In Rates on JPY 4.3 Billion in New Loans

EBR Systems advances FDA approval process for new WiSE manufacturing site

DBRS Morningstar: Rising rates to hit private corporate credit first and hardest

Morning Star AU

ADARx Pharmaceuticals indicated to open at $28, IPO priced at $17

Hoshino Resorts REIT Wins Interest Rate Cut After Hitting Sustainability Loan Targets

Insmed resumed with a Buy at Goldman Sachs

Mesoblast Wins FDA Nod for New Potency Assay on Ryoncil Batches

Kaisa Health Rebrands as Qinghai Biotech Pharmaceutical on Stock Exchange

BOE officials leave London for Leeds to set interest rates

Philip Aldrick / Bloomberg

Adagene Wins NMPA IND Clearance for Novel HER2xCD3 T-Cell Engager ADG138

Why Japan’s markets matter so much for America

Kolmar Biotech Finalizes Low-Risk Merger of Wholly Owned Unit MOD Materials

Nexsen Seeks ASX Trading Halt Ahead of RAPID-GBS Trial Update

InspireMD Announces Amendments to Certain Series J and Series K Warrants, Providing Potential Gross Proceeds of Up to $11 Million

Tiziana Life Sciences Completes Last Patient Visit in Phase 2a INFORM-MS Trial

Immunome initiated with a Buy at Alliance Global

Ultragenyx price target raised to $35 from $32 at Barclays

Innovative Drug Sector Heats Up: Spotlight on Pure-Play R&D Developers

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/BBP/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BBP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Products ETF","latestPrice":102.4978,"timestamp":1790971200000,"preClose":103.2051,"halted":0,"volume":18715,"hourTrading":{"tag":"盘后","latestPrice":102.355,"preClose":102.4978,"latestTime":"19:30 EDT","volume":12,"amount":1229.9736,"timestamp":1790983804639,"change":-0.1428,"changeRate":-0.001393,"amplitude":0},"delay":0,"changeRate":-0.0068533434878703045,"floatShares":1250004,"shares":1250004,"eps":0,"marketStatus":"Market Closed","change":-0.7073,"latestTime":"10-02 16:00:00 EDT","open":103.87,"high":103.87,"low":102.0005,"amount":1918982.2008,"amplitude":0.018114,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":103.2051,"sharesOutstanding":600004,"nav":102.494,"aum":128117601.53,"bidAskSpread":0.002439,"postHourTrading":{"tag":"盘后","latestPrice":102.355,"preClose":102.4978,"latestTime":"19:30 EDT","volume":12,"amount":1229.9736,"timestamp":1790983804639,"change":-0.1428,"changeRate":-0.001393,"amplitude":0},"volumeRatio":1.0888030521127026,"impliedVol":0.2277,"impliedVolPercentile":0.4462},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","floatShares":1250004,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.0888030521127026,"shares":1250004,"dividePrice":0,"high":103.87,"amplitude":0.018114,"preClose":103.2051,"low":102.0005,"week52Low":70.27,"pbRate":"--","week52High":110.05,"institutionHeld":0,"latestPrice":102.4978,"eps":0,"divideRate":0,"volume":18715,"delay":0,"ttmEps":0,"open":103.87,"prevYearClose":79.9149,"prevWeekClose":104.6582,"prevMonthClose":105.5872,"prevQuarterClose":105.5872,"fiveDayClose":104.6582,"twentyDayClose":108.8566,"sixtyDayClose":103.6198},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBP\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBP\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2670231456","title":"Bank of England’s Ramsden says interest rates will need to rise if pressures persist","url":"https://stock-news.laohu8.com/highlight/detail?id=2670231456","media":"cityam","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670231456?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:14","pubTimestamp":1790594093,"startTime":"0","endTime":"0","summary":"Dave Ramsden said there had been 'robust discussions' about the Bank's QT move Interest rates may need to rise if growing inflation pressures continue to build, according to the Bank of England’s deputy governor, who added there had been “robust discussion” among officials over the authority’s recent bond sale overhaul.Dave Ramsden, who leads the organisation’s oversight of markets and banking, said there would have been “at least two cuts” by now, had the US not launched its assault in the Middle East, and energy markets not been as substantially disrupted.“Bank Rate being the ‘active’ tool doesn’t always mean it has to change,” he told a finance event in London. “Indeed a decision to hold can be an active response to the risks to the inflation outlook.”","market":"us","thumbnail":"https://www.cityam.com/wp-content/uploads/2026/09/Bank-of-England-deputy-governor-Dave-Ramsden.jpg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2026/09/Bank-of-England-deputy-governor-Dave-Ramsden.jpg?w=824&h=463&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/bank-of-englands-ramsden-says-interest-rates-will-need-to-rise-if-pressures-persist/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/bank-of-englands-ramsden-says-interest-rates-will-need-to-rise-if-pressures-persist/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["TSLO","CLIX","TSLW","CRSH","TSII","FXL","BBP","PEVC","TEST","TSLS","BK4582","RJZ","UCC","BK4588","TSLZ","CAOS","FXR","TESC","TSLI","TSLT","AVSD","DFUV","BK4585","TSL","KOMP","FLGB","TSLG","TSLL","TSLR","LRCY","09766","07766","TACN","TLA","TSLQ","IDEV","VAW","TSLP","TSYY","ANEW","IJK","09366","TSLY","TESL","ELOL","TSDD","ISVL","07366","BBEU","CGDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670236928","title":"Zymeworks sees FY26 revenue $278M-$292M, consensus $304.04M","url":"https://stock-news.laohu8.com/highlight/detail?id=2670236928","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670236928?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:10","pubTimestamp":1790590220,"startTime":"0","endTime":"0","summary":"With the completion of the Theravance Biopharma acquisition and the receipt of the U.S. FDA approval of Ziihera for first-line HER2-positive advanc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zymeworks-sees-fy26-revenue-278m-292m-consensus-304-04m-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zymeworks-sees-fy26-revenue-278m-292m-consensus-304-04m-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PINK","IBB","IYH","NVIB","SYNB","LABU","LFSC","IEIH","TECB","GDOC","GNMX","BMED","PSCH","TBPH","TBXU","BK4007","BK4588","MRNY","FRTY","BBP","MEDI","BK4585","IDNA","RSPH","XLVX","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670284876","title":"Ichigo Office REIT Locks In Rates on JPY 4.3 Billion in New Loans","url":"https://stock-news.laohu8.com/highlight/detail?id=2670284876","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670284876?lang=en_us&edition=fundamental","pubTime":"2026-09-28 14:59","pubTimestamp":1790578742,"startTime":"0","endTime":"0","summary":"Ichigo Office REIT Investment Corporation ( ($JP:8975) ) just unveiled an update. Ichigo Office REIT has finalized fixed interest rates on a total ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ichigo-office-reit-locks-in-rates-on-jpy-4-3-billion-in-new-loans?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ichigo-office-reit-locks-in-rates-on-jpy-4-3-billion-in-new-loans?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TSDD","YLDW","BBP","CAOS","CRSH","TSLI","TSL","FXR","TSLZ","TSYY","TSLO","DFUV","CGDV","RJMG","TEST","LRCY","DFRA","FXL","TLA","TSLG","VAW","BPRE","PSCF","07366","AVSD","KOMP","07766","RNTY","TSLS","PEVC","TESL","TESC","ELOL","IVRA","TSII","TSLP","RJZ","ANEW","TSLW","IQRA","MDIV","TSLQ","TSLT","IJK","TSLL","TSLY","CLIX","REIT","TSLR","UCC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670402990","title":"EBR Systems advances FDA approval process for new WiSE manufacturing site","url":"https://stock-news.laohu8.com/highlight/detail?id=2670402990","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670402990?lang=en_us&edition=fundamental","pubTime":"2026-09-28 08:08","pubTimestamp":1790554084,"startTime":"0","endTime":"0","summary":"The latest announcement is out from EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( ($AU:EBR) ). EBR Systems, developer of the WiSE wi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ebr-systems-advances-fda-approval-process-for-new-wise-manufacturing-site?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ebr-systems-advances-fda-approval-process-for-new-wise-manufacturing-site?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PINK","IEIH","RSPH","IDNA","LABU","MRNX","GNMX","NVIB","TECB","EES","MEDI","FRTY","SYNB","XLVX","PSCH","BK4585","GDOC","MRNY","BMED","BBP","LFSC","IBB","TBXU","IYH","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670283878","title":"DBRS Morningstar: Rising rates to hit private corporate credit first and hardest","url":"https://stock-news.laohu8.com/highlight/detail?id=2670283878","media":"Morning Star AU","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670283878?lang=en_us&edition=fundamental","pubTime":"2026-09-28 00:00","pubTimestamp":1790524800,"startTime":"0","endTime":"0","summary":"Key takeaways:Private credit issuers are most exposed to higher interest rates because of their predominantly floating-rate debt, with rising interest expenses pressuring interest coverage and cash fl","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"morningstar_stock","url":"https://www.morningstar.com.au/markets/dbrs-morningstar-rising-rates-hit-private-corporate-credit-first-hardest","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.morningstar.com.au/markets/dbrs-morningstar-rising-rates-hit-private-corporate-credit-first-hardest","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"morningstar_stock","symbols":["JCPB","DYLD","PCMM","SDEF","CGHY","LBO","PSQO","BBP","FLRN","REDS","PSP","FXR","JOJO","KI","PCLO","RSF","IGCB","DFUV","HYUP","KOMP","OOSP","MYCI","BIZD","CCIF","PEVC","THYF","VAW","HYZD","DVDN","RJZ","FBDC","SPHQ","BDCX","CLIX","CGDV","DADS","CAOS","KAMO","PHYD","FXL","AVSD","LONZ","TSLP","UCC","AFIF","VPC","NBFC","IJK","BDCZ","ANEW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670099423","title":"ADARx Pharmaceuticals indicated to open at $28, IPO priced at $17","url":"https://stock-news.laohu8.com/highlight/detail?id=2670099423","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670099423?lang=en_us&edition=fundamental","pubTime":"2026-09-25 22:25","pubTimestamp":1790346339,"startTime":"0","endTime":"0","summary":"ADARx Pharmaceuticals (ADRX), a late-stage clinical biotechnology company developing next-generation siRNA therapeutics, priced its upsized initial...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/adarx-pharmaceuticals-indicated-to-open-at-28-ipo-priced-at-17-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/adarx-pharmaceuticals-indicated-to-open-at-28-ipo-priced-at-17-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FRHC","XT","FWD","LNGR","FHLC","KCE","JDOC","BK4588","BBP","BK4127","IPOS","IEIH","REDS","AGNG","SYNB","RSPH","DARP","IBB","BK4585","ADRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670443795","title":"Hoshino Resorts REIT Wins Interest Rate Cut After Hitting Sustainability Loan Targets","url":"https://stock-news.laohu8.com/highlight/detail?id=2670443795","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670443795?lang=en_us&edition=fundamental","pubTime":"2026-09-25 14:54","pubTimestamp":1790319243,"startTime":"0","endTime":"0","summary":"An announcement from Hoshino Resorts REIT, Inc. ( ($JP:3287) ) is now available. Hoshino Resorts REIT, Inc. has announced that interest rates on se...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/hoshino-resorts-reit-wins-interest-rate-cut-after-hitting-sustainability-loan-targets?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/hoshino-resorts-reit-wins-interest-rate-cut-after-hitting-sustainability-loan-targets?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IVRA","DFUV","RJZ","TSYY","LRCY","09766","CGDV","TSLO","CAOS","PEVC","TSLQ","TSLG","TSLZ","BPRE","TLA","TSLW","FXR","TSLI","VAW","TSL","09366","TSLS","CLIX","FXL","CRSH","YLDW","ANEW","TSLR","IJK","AVSD","TSDD","ELOL","PSCF","TEST","TSLL","MDIV","TSLP","TSLT","DFRA","TESC","TSLY","IQRA","REIT","RJMG","KOMP","BBP","UCC","TSII","TESL","RNTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669656404","title":"Insmed resumed with a Buy at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2669656404","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669656404?lang=en_us&edition=fundamental","pubTime":"2026-09-24 16:45","pubTimestamp":1790239509,"startTime":"0","endTime":"0","summary":"Goldman Sachs resumed coverage of Insmed (INSM) with a Buy rating and $188 price target Goldman resumed coverage of the biotechnology sector, sayin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/insmed-resumed-with-a-buy-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/insmed-resumed-with-a-buy-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2471134796.USD","IEIH","KQQQ","LU0868494708.USD","NFEB","IGM","BK4585","AGNG","LU2750360997.AUD","LU0109394709.USD","LU1868837300.USD","SYNB","LU0053671581.USD","LU2471134523.USD","RKSG","DARP","XT","LU2237443895.HKD","TBXU","INSM","XLK","IBB","LU1868836757.USD","IE00B19Z3581.USD","BIOY","LU2896262040.SGD","BBP","GSX","LU2237443549.SGD","LU2237443978.SGD","LNGR","LU1804176565.USD","LU0320765992.SGD","BK4552","BK4533","BK4588","LU0106831901.USD","FWD","LU1868837136.USD","IE0004086264.USD","APXH","LU2265009873.SGD","RSPH","XLSR","WDNA","JDOC","LU2237443465.HKD","LU1894683264.USD","LU0061475181.USD","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669437128","title":"Mesoblast Wins FDA Nod for New Potency Assay on Ryoncil Batches","url":"https://stock-news.laohu8.com/highlight/detail?id=2669437128","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669437128?lang=en_us&edition=fundamental","pubTime":"2026-09-24 08:30","pubTimestamp":1790209807,"startTime":"0","endTime":"0","summary":"An announcement from Mesoblast Limited ( ($AU:MSB) ) is now available. Mesoblast has secured U.S. FDA approval for a new T-cell Proliferation Inhib...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mesoblast-wins-fda-nod-for-new-potency-assay-on-ryoncil-batches?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mesoblast-wins-fda-nod-for-new-potency-assay-on-ryoncil-batches?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FRTY","BK4585","MRNX","IDNA","XLVX","IBB","MEDI","BBP","RSPH","LABU","IYH","TBXU","LFSC","PSCH","BMED","TECB","BK4139","IEIH","GNMX","MESO","BK4588","GDOC","SYNB","MRNY","PINK","NVIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188760602","title":"Kaisa Health Rebrands as Qinghai Biotech Pharmaceutical on Stock Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=1188760602","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188760602?lang=en_us&edition=fundamental","pubTime":"2026-09-23 22:46","pubTimestamp":1790174774,"startTime":"0","endTime":"0","summary":"Kaisa Health (00876) has announced a corporate identity overhaul, with its official English name transitioning from \"Kaisa Health Group Holdings Limited\" to \"Qinghai Biotech Pharmaceutical Group...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03069","BK1222","MRNY","02954","BK1121","BK1239","MRNX","BK1230","00876","BBP","BK1154","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669343196","title":"BOE officials leave London for Leeds to set interest rates","url":"https://stock-news.laohu8.com/highlight/detail?id=2669343196","media":"Philip Aldrick / Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669343196?lang=en_us&edition=fundamental","pubTime":"2026-09-23 10:16","pubTimestamp":1790129761,"startTime":"0","endTime":"0","summary":"Monetary Policy Committee's nine members will travel north to the BOE's offices in the West Yorkshire city to thrash out their rate decision, inaugurating a new phase in the bank's 332-year history.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"edge_highlight","url":"https://www.theedgesingapore.com/news/banking-finance/boe-officials-leave-london-leeds-set-interest-rates?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theedgesingapore.com/news/banking-finance/boe-officials-leave-london-leeds-set-interest-rates?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"edge_highlight","symbols":["07766","DFUV","TSLW","TSLG","BK4585","CAOS","CGDV","FXL","UCC","CLIX","TESL","CRSH","TSLR","TSLZ","VAW","BK4588","TSLT","KOMP","AVSD","TSLS","09366","BBP","FXR","TSII","TEST","TLA","TSYY","TSLP","LRCY","TSLY","TSDD","TSLI","TSLO","IJK","TSLL","PEVC","TSL","TESC","BOE","07366","ELOL","09766","RJZ","ANEW","TSLQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669144262","title":"Adagene Wins NMPA IND Clearance for Novel HER2xCD3 T-Cell Engager ADG138","url":"https://stock-news.laohu8.com/highlight/detail?id=2669144262","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669144262?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:27","pubTimestamp":1790080070,"startTime":"0","endTime":"0","summary":"Adagene ( ($ADAG) ) has issued an announcement. Adagene Inc., a platform-driven, clinical-stage biotechnology company listed on Nasdaq, specializes...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adagene-wins-nmpa-ind-clearance-for-novel-her2xcd3-t-cell-engager-adg138?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adagene-wins-nmpa-ind-clearance-for-novel-her2xcd3-t-cell-engager-adg138?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","BK4588","AGNG","BBC","IBB","SYNB","BK4585","FHLC","LNGR","JDOC","XT","FWD","LCLG","IEIH","BK4139","ADAG","NQmain","BBP","DARP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669989113","title":"Why Japan’s markets matter so much for America","url":"https://stock-news.laohu8.com/highlight/detail?id=2669989113","media":"CNN Business","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669989113?lang=en_us&edition=fundamental","pubTime":"2026-09-22 12:01","pubTimestamp":1790049689,"startTime":"0","endTime":"0","summary":"From surging bond yields to US intervention to support the yen, Japan’s financial markets are undergoing major shifts that have consequences for investors and borrowing costs around the globe.Bond yields in Japan have soared to their highest levels in three decades, boosted by inflation, the Bank of Japan raising interest rates and investors’ concerns about the government’s spending plans. Meanwhile, the yen continues to fluctuate after a historic joint intervention by Washington and Tokyo.The moves in Japan’s bonds and currency have reverberations across the global economy. Japan is the largest foreign holder of US Treasuries, making it a key player for how much money flows in or out of US bond markets.US Treasury Secretary Scott Bessent has embarked on an extraordinary campaign this year to intervene in markets to support the yen. Analysts say Bessent’s actions aim to prevent Japan from selling its dollar assets – like Treasuries – to boost the value of the yen. Further selling in Tr","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"cnn_highlight","url":"https://edition.cnn.com/2026/09/22/economy/us-japan-bond-markets-yen","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://edition.cnn.com/2026/09/22/economy/us-japan-bond-markets-yen","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cnn_highlight","symbols":["KOMP","CLIX","TSL","TSDD","LRCY","PEVC","FXL","FXY","HEWJ","YCL","AVSD","TSLQ","UCC","07366","BK4585","CGDV","CDIG","TSLT","TSYY","TLA","DFUV","YCS","TSLG","TESL","09766","ANEW","TSLY","TSLZ","CRSH","TSLR","TSII","BBP","CAOS","IJK","TEST","TSLS","VAW","09366","TESC","TSLI","BK4588","TSLW","07766","FXR","TSLP","RJZ","ELOL","TSLL","TSLO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669192951","title":"Kolmar Biotech Finalizes Low-Risk Merger of Wholly Owned Unit MOD Materials","url":"https://stock-news.laohu8.com/highlight/detail?id=2669192951","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669192951?lang=en_us&edition=fundamental","pubTime":"2026-09-22 09:14","pubTimestamp":1790039644,"startTime":"0","endTime":"0","summary":"WOOJUNG BIO, Inc. ( ($KR:215380) ) has issued an update. Kolmar Biotech Co., Ltd., a biotechnology and advanced materials company based in Hwaseong...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kolmar-biotech-finalizes-low-risk-merger-of-wholly-owned-unit-mod-materials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kolmar-biotech-finalizes-low-risk-merger-of-wholly-owned-unit-mod-materials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARKG","LNGR","JDOC","XBI","UYM","XT","TYNE","AGNG","DARP","BK4588","BBP","TINT","SYNB","BK4544","FHLC","IBB","IEIH","BK4585","BK4581","RSPH","FWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669199837","title":"Nexsen Seeks ASX Trading Halt Ahead of RAPID-GBS Trial Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2669199837","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669199837?lang=en_us&edition=fundamental","pubTime":"2026-09-22 07:34","pubTimestamp":1790033657,"startTime":"0","endTime":"0","summary":"Nexsen Limited ( ($AU:NXN) ) just unveiled an announcement. Nexsen Limited, trading on the ASX as NXN, operates in the healthcare and biotechnology...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nexsen-seeks-asx-trading-halt-ahead-of-rapid-gbs-trial-update?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nexsen-seeks-asx-trading-halt-ahead-of-rapid-gbs-trial-update?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LNGR","BK4588","AGNG","DARP","BK4550","VHT","IEIH","XT","CGCV","BK4585","RSPH","FHLC","IXJ","BBP","JDOC","FWD","IBB","TCAF","NOBL","SYNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669316610","title":"InspireMD Announces Amendments to Certain Series J and Series K Warrants, Providing Potential Gross Proceeds of Up to $11 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2669316610","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669316610?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:00","pubTimestamp":1789995600,"startTime":"0","endTime":"0","summary":"- Amendments align trigger event of existing warrants with anticipated FDA approval of CGuard Prime 80 cm, which the Company continues to anticipate in Q4 2026 - - The amended warrants, if exercised i","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/21/3365503/0/en/inspiremd-announces-amendments-to-certain-series-j-and-series-k-warrants-providing-potential-gross-proceeds-of-up-to-11-million.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDOC","IDNA","MRNY","LFSC","PSCH","IEIH","SYNB","MEDI","GNMX","RSPH","MRNX","PINK","NSPR","BMED","BK4585","BBP","BK4588","IBB","NVIB","TBXU","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669684681","title":"Tiziana Life Sciences Completes Last Patient Visit in Phase 2a INFORM-MS Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2669684681","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669684681?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:27","pubTimestamp":1789990051,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences ( ($TLSA) ) has shared an announcement. Tiziana Life Sciences Ltd, a clinical-stage biotechnology company specializing in imm...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tiziana-life-sciences-completes-last-patient-visit-in-phase-2a-inform-ms-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tiziana-life-sciences-completes-last-patient-visit-in-phase-2a-inform-ms-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SYNB","BK4588","BBC","FWD","IBB","RSPH","IEIH","BBP","DARP","JDOC","XT","LNGR","BK4585","AGNG","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669893168","title":"Immunome initiated with a Buy at Alliance Global","url":"https://stock-news.laohu8.com/highlight/detail?id=2669893168","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669893168?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:05","pubTimestamp":1789988705,"startTime":"0","endTime":"0","summary":"Alliance Global initiated coverage of Immunome (IMNM) with a Buy rating and $32 price target Immunome is a biotechnology company focused on develop...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/immunome-initiated-with-a-buy-at-alliance-global-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/immunome-initiated-with-a-buy-at-alliance-global-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FHLC","LNGR","BK4585","BBP","JDOC","BK4588","AGNG","DARP","FWD","IMNM","SYNB","XT","IBB","RSPH","BK4139","BK4563","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669442151","title":"Ultragenyx price target raised to $35 from $32 at Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2669442151","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669442151?lang=en_us&edition=fundamental","pubTime":"2026-09-21 17:10","pubTimestamp":1789981807,"startTime":"0","endTime":"0","summary":"Barclays raised the firm’s price target on Ultragenyx (RARE) to $35 from $32 and keeps an Overweight rating on the shares following FDA approval of...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ultragenyx-price-target-raised-to-35-from-32-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ultragenyx-price-target-raised-to-35-from-32-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FRTY","IDNA","TBXU","BMED","BK4588","LABU","PSCH","RSPH","GDOC","BK4139","MRNX","RARE","PINK","SYNB","IBB","MEDI","GNMX","LFSC","TECB","XLVX","MRNY","BK4585","IYH","IEIH","NVIB","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181721651","title":"Innovative Drug Sector Heats Up: Spotlight on Pure-Play R&D Developers","url":"https://stock-news.laohu8.com/highlight/detail?id=1181721651","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181721651?lang=en_us&edition=fundamental","pubTime":"2026-09-21 14:01","pubTimestamp":1789970464,"startTime":"0","endTime":"0","summary":"A bullish MACD crossover signal has emerged, indicating strong upward momentum for select pharmaceutical stocks. This technical indicator, often seen as a precursor to sustained gains, has caught the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBE","SBIO","GDOC","BK4585","BK4588","BK1161","BBP","LFSC","MEDX","GSKH","APXH","IBBQ","BK1574","159992","BIOY","06978","XLVI","LNGR","IBB","WRND"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}